Pulmonx (LUNG) EBT Margin Growth (1y) (2020 - 2025)
Pulmonx (LUNG) EBT Margin Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -419.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 110.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -300.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 507.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -287.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 233.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 772.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -464.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 584.00 |
| 10 | Pulmonx | 54.38 Mn | -15.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 412.00 |
| Jun 30, 2025 | 1,049.00 |
| Mar 31, 2025 | 843.00 |
| Dec 31, 2024 | 1,548.00 |
| Sep 30, 2024 | 1,556.00 |
| Jun 30, 2024 | 2,004.00 |
| Mar 31, 2024 | 3,633.00 |
| Dec 31, 2023 | 2,025.00 |
| Sep 30, 2023 | 2,096.00 |
| Jun 30, 2023 | 1,128.00 |
| Mar 31, 2023 | 3,788.00 |
| Dec 31, 2022 | 277.00 |
| Sep 30, 2022 | -2,852.00 |
| Jun 30, 2022 | 90.00 |
| Mar 31, 2022 | -1,151.00 |
| Dec 31, 2021 | 59.00 |
| Sep 30, 2021 | -4,053.00 |
| Jun 30, 2021 | 21,720.00 |
| Mar 31, 2021 | -5,252.00 |
| Dec 31, 2020 | -5,066.00 |